PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15659233-3	2005	Intracerebroventricular administration of 1 microg CART peptide (55-102) produced increases in 3,4-dihydroxyphenylacetic acid (DOPAC) levels in the nucleus accumbens (NA) at 15 and 45 min, and in the striatum (ST) at 15 min, but not in the medial prefrontal cortex (MPFC).	3,4-Dihydroxyphenylacetic Acid	95-125	CART prepropeptide	Rattus norvegicus	51-55	
18554810-3	2008	administration of the CART peptide (55-102, 1 microg/3 microl) increased dopamine turnover (3,4-dihydroxyphenylacetic acid, DOPAC) in the nucleus accumbens (NA) and striatum (ST) in ovariectomized (OVX) female Sprague-Dawley rats with E(2)-priming.	3,4-Dihydroxyphenylacetic Acid	92-122	CART prepropeptide	Rattus norvegicus	22-26	
18554810-3	2008	administration of the CART peptide (55-102, 1 microg/3 microl) increased dopamine turnover (3,4-dihydroxyphenylacetic acid, DOPAC) in the nucleus accumbens (NA) and striatum (ST) in ovariectomized (OVX) female Sprague-Dawley rats with E(2)-priming.	3,4-Dihydroxyphenylacetic Acid	124-129	CART prepropeptide	Rattus norvegicus	22-26	
18554810-4	2008	This stimulation of NA and ST DOPAC contents by CART peptide was found in OVX+E(2) female rats, but not in OVX only female rats, suggesting E(2) is an important factor in modulating the stimulatory effect of CART in the regulation of NA and ST DOPAC contents.	3,4-Dihydroxyphenylacetic Acid	30-35	CART prepropeptide	Rattus norvegicus	48-52	
18554810-4	2008	This stimulation of NA and ST DOPAC contents by CART peptide was found in OVX+E(2) female rats, but not in OVX only female rats, suggesting E(2) is an important factor in modulating the stimulatory effect of CART in the regulation of NA and ST DOPAC contents.	3,4-Dihydroxyphenylacetic Acid	244-249	CART prepropeptide	Rattus norvegicus	48-52	
15659233-3	2005	Intracerebroventricular administration of 1 microg CART peptide (55-102) produced increases in 3,4-dihydroxyphenylacetic acid (DOPAC) levels in the nucleus accumbens (NA) at 15 and 45 min, and in the striatum (ST) at 15 min, but not in the medial prefrontal cortex (MPFC).	3,4-Dihydroxyphenylacetic Acid	127-132	CART prepropeptide	Rattus norvegicus	51-55	
15659233-6	2005	However, only MCH prevented the stimulatory effect of CART peptide on DOPAC levels in the NA, but not in the ST.	3,4-Dihydroxyphenylacetic Acid	70-75	CART prepropeptide	Rattus norvegicus	54-58	
34287909-7	2021	On the other hand, immunoneutralization of endogenous CART with CART antibodies injected directly in the pVTA or PVT reduced the lever press activity as well as DA and DOPAC efflux in the AcbSh.	3,4-Dihydroxyphenylacetic Acid	168-173	CART prepropeptide	Rattus norvegicus	54-58	
15212972-2	2004	Intracerebroventricular injections of various doses (0.1-5 microg/5 microl/rat) of CART(55-102) elicited dose-dependent increases of extracellular DOPAC and HVA concentration in the AcbSh, suggesting that CART(55-102) peptide has a psychostimulant-like effect via activation of the mesolimbic dopaminergic system.	3,4-Dihydroxyphenylacetic Acid	147-152	CART prepropeptide	Rattus norvegicus	83-87	
12726825-3	2003	The CART peptide stimulated DOPAC levels in the striatum (ST), nucleus accumbens (NA), hypothalamic paraventricular nucleus (PVN), and periventricular (A14), but had no effect in the medial prefrontal cortex (MPFC) or suprachiasmatic nucleus (SCN).	3,4-Dihydroxyphenylacetic Acid	28-33	CART prepropeptide	Rattus norvegicus	4-8	
34287909-7	2021	On the other hand, immunoneutralization of endogenous CART with CART antibodies injected directly in the pVTA or PVT reduced the lever press activity as well as DA and DOPAC efflux in the AcbSh.	3,4-Dihydroxyphenylacetic Acid	168-173	CART prepropeptide	Rattus norvegicus	64-68